GeneReach Biotechnology Market Cap

GeneReach Biotechnology has a market cap or net worth of 1.14 billion as of May 9, 2025. Its market cap has decreased by -39.91% in one year.

Market Cap

1.14B

Enterprise Value

909.64M

Revenue

206.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

19.80

Market Cap Chart

Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.14B, a decrease of -10.60%. That is a compound annual growth rate of -0.89%.

Market Cap History

Date	Market Cap	% Change
May 9, 2025	1.14B	-30.89%
Dec 31, 2024	1.65B	-27.38%
Dec 29, 2023	2.27B	-25.28%
Dec 30, 2022	3.03B	-20.04%
Dec 30, 2021	3.79B	-27.82%
Dec 31, 2020	5.26B	91.85%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	176.85B
Caliway Biopharmaceuticals	108.07B
Bora Pharmaceuticals Co., LTD.	72.61B
Lotus Pharmaceutical	59.38B
Polaris Group	31.12B
Oneness Biotech	28.12B
Lumosa Therapeutics	27.28B
Pegavision	26.83B

Market Cap Rankings